Aspiriant LLC’s Altria Group MO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$372K Buy
5,174
+681
+15% +$47.5K 0.01% 289
2026
Q1
$297K Buy
+4,493
New +$289K 0.01% 276
2025
Q3
Sell
-3,538
Closed -$207K 308
2025
Q2
$207K Buy
+3,538
New +$208K 0.01% 302
2023
Q4
Sell
-4,895
Closed -$206K 313
2023
Q3
$206K Buy
+4,895
New +$216K 0.01% 270
2022
Q2
Sell
-11,877
Closed -$620K 286
2022
Q1
$620K Buy
+11,877
New +$605K 0.03% 156
2020
Q4
Sell
-9,924
Closed -$383K 215
2020
Q3
$383K Buy
+9,924
New +$413K 0.03% 169
2018
Q4
Sell
-3,390
Closed -$203K 244
2018
Q3
$203K Buy
+3,390
New +$201K 0.02% 228
2017
Q3
Sell
-6,002
Closed -$447K 213
2017
Q2
$447K Buy
+6,002
New +$439K 0.04% 147

Other funds holding MO

Aspiriant LLC's MO Position: Q2 2026 in Review

Aspiriant LLC increased its Altria Group (MO) stake by 15% in Q2 2026, buying an estimated $47.5K and bringing the position to 5,174 shares worth $372K. The position accounts for 0.01% of the portfolio, ranked #289.

Aspiriant LLC first reported a position in MO in Q2 2017 and has held it in 8 quarters since. The position peaked at $620K in Q1 2022. 2,556 funds tracked by Wall St. Rank hold MO as of Q2 2026.

  • Aspiriant LLC held 5,174 shares of Altria Group worth $372K as of Q2 2026.
  • Aspiriant LLC bought 681 Altria Group shares in Q2 2026, an estimated $47.5K.
  • Altria Group made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #289 holding.
  • Aspiriant LLC first reported a position in Altria Group in Q2 2017 and has held it in 8 quarters since.
  • Aspiriant LLC's Altria Group position peaked at $620K in Q1 2022.
  • 2,556 funds tracked by Wall St. Rank held Altria Group as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.